We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

HORIBA Medical

HORIBA ABX designs, develops and distributes worldwide, in vitro diagnostic systems for biological analysis in medica... read more Featured Products: More products

Download Mobile App





HORIBA Exhibits Compact Benchtop Hematology Analyzers

By LabMedica International staff writers
Posted on 03 Feb 2025

HORIBA (Kyoto, Japan) is presenting its latest IVD solutions at Medlab Middle East 2025, including the

labmedica.com/expo/product/4456/automated-hematology-analyzer-model-yumizen-h550" target="_blank">Yumizen H550 and H500 hematology analyzers.

The HORIBA Medical Segment designs, develops, and distributes worldwide, in vitro diagnostic systems mainly destined for biological analysis in medical laboratories. These automated analyzers meet the needs of various users including patients, doctors, private laboratories, clinics, and university hospitals. HORIBA’s expertise in vitro diagnostics is one of the most respected in hematology worldwide. The new generation of HORIBA’s automated hematology analyzer offers solid and reliable diagnostic technology as well as rapid and consistent results. HORIBA provides a wide range of hematology analyzers and automated instruments to realize blood analysis (blood cell identification and counting) for the diagnosis of various blood-related diseases. These instruments are designed for all kinds of laboratories, from small laboratories (to 150 patients a day), to larger ones (more than 2000 patients a day). These efficient and reliable instruments feature automated racks, data management, and quality tools providing a complete solution for meeting high-quality medical analysis requirements.

The new Yumizen H500 and H550 compact benchtop hematology analyzers featured at Medlab Middle East 2025 deliver enhanced performance, new features, and increased benefits. Both analyzers come with optional infectious flags for malaria and dengue, making them ideal for small labs to meet a variety of clinical lab environments and settings such as routine hematology, satellite labs, oncology care, and blood banks. HORIBA is also highlighting HELO 2.0, an innovative solution covering all the needs of a high throughput automated hematology platform. Flexible and efficient, HELO 2.0 is the optimum answer to the constant evolution of laboratories. Thanks to its data, tube management, waste, blood film, and digitalization management capability, HELO 2.0 not only fulfills all the needs of laboratories but also helps optimize their TAT, floor space, and reagent storage.


Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
Gold Member
Automatic Hematology Analyzer
DH-800 Series
Gold Member
Automated MALDI-TOF MS System
EXS 3000
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Research has linked platelet aggregation in midlife blood samples to early brain markers of Alzheimer’s (Photo courtesy of Shutterstock)

Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk

Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more

Microbiology

view channel
Image: Development of targeted therapeutics and diagnostics for extrapulmonary tuberculosis at University Hospital Cologne (Photo courtesy of Michael Wodak/Uniklinik Köln)

Blood-Based Molecular Signatures to Enable Rapid EPTB Diagnosis

Extrapulmonary tuberculosis (EPTB) remains difficult to diagnose and treat because it spreads beyond the lungs and lacks easily accessible biomarkers. Despite TB infecting 10 million people yearly, the... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.